We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
If SPI, can break last high of 250, on 8/2/23, this would bring the sp, above any overhead supply from previous trading activity. There is a clear bullish uptrend, in place , and the 5 year chart, low price , difference added to 250, implies a target price of 448. Chart trendline, can provide a nearby stop loss level. The underlying sector, was strongest sector today. DYOR.
LOL...yeah guess I did, must be my age and probably could do with some good quality healthcare...
Guess your 140, was meant to be 240, since sp, 232.
Plenty of good news in the Results, improved dividend and broker ratings...looking to get back above 140 at least....
Spire Healthcare plc posted its HY Report for the 6 months ended 30th June 2023 this morning. Revenue was up 13.1% vs H1 22 to £676.5m, driven by continued strong demand, adjusted EBIT was up 24.2% vs H1 22 to £67.8m and adjusted EBITDA was up 11.4% vs H1 22 to £117.9m. Statutory profit after tax was up to £12.7m (H1 22: loss of £0.6m). Meanwhile the balance sheet improved, with net bank debt / EBITDA covenant ratio of 2.1x at 30 June 2023 (2.2x at the end of FY22.) Valuation still remains a headwind to the investment case with forward PE ratio at 25.3x and dividend yield a little feeble at 1.15%. The share price also lacks positive momentum and has been drifting sideways for 2 and half years. SPI remains a share to monitor for the time being. ..
...from WealthOracle
wealthoracle.co.uk/detailed-result-full/SPI/796
Added a few. P/E still 30. No interim dividend.
Some improvement on last year and maybe gaining some momentum...very possible dividend for end of year too...not bad set of results.
Are you invested in SPI?....you could have waited until morning to comment, some of us need to sleep tonight lol
Margins must have been under great pressure with wage rises and Consultants especially must have raked it in. Minimal profit I suspect and a low EPS. I suspect revenue will be up given the dire state of the NHS.
Agreed equity has been in trading range for some while. If sp, can break short term trendline at 223, on a closing basis , target is,257. This is based on triangle formation in the price. Keep a stop in place, as the equity has disappointed previous commentators .
Interim Results have been announced in a timely manner....as we do not get periodic updates it will be interesting to find out if good profits have been made this half......
Don't think Spire will perform as it should until Ash and crew have been moved on. Profitability remains about half the industry average. Fresh approach needed with this one.
I'd held these for years, bought at 333p.
I saw Naked Trader mentioning these as a trading range share.
Sold mine at 239p for a loss, but keeping an eye for a re-entry price.
Missed the last one, but might have a go on any future dips.
Seems to regularly swing 210p - 240p. Several 30p bites far more likely to get my money back than waiting forever to get back to 333p.
Looking for 235 exit
206 hit let's see whether rang starts again
Looking for 206 entry, nice little trading range at the moment on this
I'll keep holding for my £3......
Good weekend and GLA
RBC raises Spire Healthcare to 'outperform' (sector perform) - price target 270 (230) pence
Ash has decimated profits
Balance sheet is awful with high debt
Jefferies raises Spire Healthcare to 'buy' (hold) - price target 250 (240) pence
If the true value is 90p why would someone offer £3.15
P/E of 60 is what you need to focus on. 10 is considered reasonable. 15 to 20 max for a healthcare stock.
This should be trading around a pound, no more.
Profit of just £8M? Awful.
The board turned down an offer of 315p!
Simply to save their own undeserved fat cat salaries. Like I said clowns. Ash especially. Shareholders got shafted and saw shares collapse to 90p which is true value here without new management and a new CEO
You should get your facts straight..... did you not read the March RNS?
Revenue up 8.3% to £1,198.5m, driven by increased private treatment; private revenue up by 14.5%
· Average revenue per case up 10.3% to £3,179; admissions up 7.8% to 262,801
· Adjusted EBIT up 30.2% to £105.6m and Adjusted EBITDA up 14.2% to £203.5m
· ROCE(7) increased to 6.2% (FY21: 4.9%)
· Profit after taxation of £8.2m (FY21: loss of £8.9m)
· Growth delivered despite material impacts from COVID, raised sickness and workforce pressure
· Good cost management with Adjusted EBITDA margin up from 16.1% to 17.0%
· Continued support for the NHS especially on 104-week waiting patients and orthopaedics
· Repaid £100m of bank loan and completed re-financing of the Group's £325m funding facilities
No hospitals in central London but 7 in and around the m25 ring road. How do you know there are inflation clauses in the lease agreements? Or is this just speculation?
At least it has not faired as badly as TLY (another IC BUY tip). SPI looks like either a long term hold for me now until it recovers (if ever) or a trading share where I average down and hope that it comes back to +220p. It seems to be trading between 200p and 250p. However, as ever timing the trade is key here. GLA